PHINIA (PHIN) Earnings Analysis
PHINIA (PHIN) next reports earnings on 2026-07-30, consensus EPS 1.58 USD. Last quarter (2026-04-30) it beat with EPS 1.29 USD vs 1.13 USD est (+14.2%). It has beaten estimates in 3/6 recent quarters (50%). Trailing P/E 21.91.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does PHIN next report earnings?
| Next earnings date | 2026-07-30 |
|---|---|
| Consensus EPS estimate | 1.58 USD |
| Revenue estimate | 0.92B |
PHIN earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-30 | 1.29 USD | 1.13 USD | +14.2% | Beat |
| 2026-02-12 | 1.18 USD | 1.35 USD | -12.6% | Miss |
| 2025-07-24 | 1.27 USD | 0.99 USD | +28.3% | Beat |
| 2025-04-25 | 0.94 USD | 1.04 USD | -9.6% | Miss |
| 2025-02-13 | 0.71 USD | 0.8 USD | -11.3% | Miss |
| 2024-10-31 | 1.17 USD | 0.79 USD | +48.1% | Beat |
Beat rate: 3/6 (50%) over reported quarters with consensus data.
PHIN valuation and analyst view
| Trailing P/E | 21.91 |
|---|---|
| Trailing EPS | 3.644 USD |
| Price / book | 1.99 |
| Dividend yield | 1.43% |
| Market cap | 2.94B |
| Analyst consensus | Hold (2 buy / 3 hold / 0 sell) |
| Avg price target | 93 USD |
Related research pages
Frequently asked questions
When is PHINIA (PHIN)'s next earnings date?
PHINIA is next scheduled to report on 2026-07-30, with a consensus EPS estimate of 1.58 USD and revenue estimate of 0.92B.
Did PHIN beat earnings last quarter?
In its 2026-04-30 report, PHIN posted EPS of 1.29 USD versus a 1.13 USD estimate — a beat of 14.2%.
What is PHIN's earnings track record?
Over the last 6 reported quarters with consensus data, PHIN beat estimates 3 times (50%).
What is PHIN's current P/E ratio and EPS?
PHIN trades at a trailing P/E of 21.91 on trailing EPS of 3.643505000129202 USD.
What do analysts rate PHIN?
Analyst consensus is "Hold" across 5 ratings (0 strong buy, 2 buy, 3 hold, 0 sell, 0 strong sell). Average 12-month price target: 93 USD.